tyrosine kinase inhibitors
Advertisement
Assessing the Efficacy of Osimertinib in Patients With EGFR-Mutated Lung Cancer With Bone Metastases
Three patient case reports showed that osimertinib is a promising and viable treatment option for lung cancer with bone mets.
Authors of a study, published in Lung Cancer, evaluated real-world data from US patients with metastatic non-squamous ...
In the recent GAP BRAIN trial, researchers evaluated gefitinib, a tyrosine kinase inhibitor (TKI), with or without ...
In a recent study, researchers evaluated the safety and efficacy of first-line rezivertinib (BPI-7711), a ...
Hypertension is a common adverse effect associated with the use of tyrosine kinase inhibitors (TKIs), such as axitinib. ...
DocWire News interviews Dr. Joshua Sabari, of the Perlmutter Cancer Center at NYU Langone Health, about recent results ...
Frontline Tagrisso® Improves Survival Compared With Other Tyrosine Kinase Inhibitors for Lung Cancer
First-line Tagrisso® (osimertinib) improved overall survival (OS) compared with a comparator tyrosine kinase inhibitor ...
Cardiac, vascular and hypertension treatment-emergent adverse events (TEAE) rates were similarly low with the tyrosine ...
Advertisement
630 Madison Ave.
Manalapan, NJ 07726
© 2025 Mashup Media, LLC, a Formedics Property. All Rights Reserved.